SCHEDULE 13G

Company

Sonoma Pharmaceuticals, Inc.

Filed

May 16, 2008

Accession Number

0000950134-08-009703

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →